Efficacy and safety profile of nivolumab for Japanese patients with metastatic renal cell cancer

ConclusionsNivolumab has a relatively favorable efficacy and safety profile for Japanese metastatic renal cell cancer patients in clinical practice.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research